Madrigal Pharmaceuticals, Inc. (MDGL) earnings
MDGL earnings moved a median of -0.48% by the close. Quarterly and annual MDGL reports and results, each read against the price at its own news timestamp. Back to the MDGL overview →
17 measured MDGL earnings events.
Where these MDGL earnings landedvs 17 measured MDGL earnings reactions
| Middle 50% of MDGL earnings reactions | -2.46% to +1.82% |
|---|---|
| Median reaction (to close) | -0.48% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 MDGL earnings events with a measured close landed between -2.46% and +1.82%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates | Press release | -5.10% | -2.46% | |
| Madrigal Pharmaceuticals to Release Second-Quarter 2026 Financial Results and Host Webcast on July 30, 2026 | Press release | -0.32% | -0.74% | |
| Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates | Press release | +3.20% | +1.61% | |
| Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026 | Press release | -1.36% | -0.48% | |
| Madrigal Pharmaceuticals Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates | Press release | +3.85% | +9.46% | |
| Madrigal Pharmaceuticals to Release Third-Quarter 2025 Financial Results and Host Webcast on November 4, 2025 | Press release | +0.26% | -2.49% | |
| Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates | Press release | -7.13% | -3.17% | |
| Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025 | Press release | +0.19% | -0.17% | |
| Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates | Press release | -8.34% | -6.10% | |
| Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025 | Press release | -5.02% | -1.42% | |
| Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates | Press release | -0.79% | +5.57% | |
| Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024 | Press release | +0.81% | +1.06% | |
| Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates | Press release | -1.38% | -5.99% | |
| Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024 | Press release | +1.63% | +1.82% | |
| Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates | Press release | +0.86% | -1.82% | |
| Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024 | Press release | -1.28% | +2.61% | |
| Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results | Press release | +1.05% | +2.80% |
Keep exploring
More MDGL: analyst actions → · SEC filings → · MDGL overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| INNATE PHARMA (IPHYF) | 130 | 0.00% | 0% |
| Deciphera Pharmaceuticals, Inc. (DCPH) | 129 | +0.04% | 55% |
| Medicenna Therapeutics Corp (MDNA_TSE) | 127 | 0.00% | 46% |
| OPGEN INC (OPGN) | 127 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.